Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 10/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 10/20 | 0.48 |
| ▸ | NPC1 | O15118 | 3/20 | 0.42 |
| ▸ | RAB9A | P51151 | 3/20 | 0.42 |
| ▸ | APP | P05067 | 4/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.38 |
| ▸ | RELA | Q04206 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5045097 | 0.87 | KDM4E (0.47) | NPC1RAB9AKDM4EALDH1A1MAPT | |
| SCHEMBL5042047 | 0.84 | TLR7 (0.37) | HDAC6MAPTSMN1; SMN2GPR119 | |
| SCHEMBL5044889 | 0.84 | TLR7 (0.43) | APPHDAC6MAPTSMN1; SMN2GPR119 | |
| SCHEMBL5041479 | 0.83 | MAPT (0.38) | ESR1ESR2HDAC6MAPTSMN1; SMN2 | |
| SCHEMBL5050052 | 0.82 | TLR7 (0.37) | ESR1ESR2HDAC6MAPTSMN1; SMN2 | |
| SCHEMBL5045843 | 0.81 | ESR1 (0.55) | ESR1ESR2NPC1RAB9AAPP | |
| SCHEMBL5049478 | 0.80 | MAPT (0.37) | HDAC6MAPTSMN1; SMN2GPR119 | |
| SCHEMBL435678 | 0.79 | KDM4E (0.46) | ESR1ESR2KDM4EALDH1A1MAPT | |
| SCHEMBL5042036 | 0.75 | KDM4E (0.43) | NPC1RAB9AKDM4EALDH1A1MAPT | |
| SCHEMBL8577901 | 0.74 | TP53 (0.58) | NPC1RAB9AKDM4EALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7414138-B2 | Benzoxazole and benzodiazole UV-A sunscreens | DSM IP ASSETS B.V. (NL) | 2008-08-19 | — | — | US | claimed |
| US-20050260144-A1 | Benzoxazole and benzodiazole uv-a sunscreens | DSM IP ASSETS B.V. (NL) | 2005-11-24 | — | — | US | claimed |
| EP-1515694-A1 | BENZOXAZOLE AND BENZODIAZOLE UV-A SUNSCREENS | DSM IP Assets B.V. (NL) | 2005-03-23 | — | — | EP | claimed |
| WO-2004000256-A1 | BENZOXAZOLE AND BENZODIAZOLE UV-A SUNSCREENS | DSM IP ASSETS B.V. (NL) | 2003-12-31 | — | — | WO | claimed |
| US-7414138-B2 | Benzoxazole and benzodiazole UV-A sunscreens | DSM IP ASSETS B.V. (NL) | 2008-08-19 | — | — | US | disclosed |
| US-20050260144-A1 | Benzoxazole and benzodiazole uv-a sunscreens | DSM IP ASSETS B.V. (NL) | 2005-11-24 | — | — | US | disclosed |
| EP-1515694-A1 | BENZOXAZOLE AND BENZODIAZOLE UV-A SUNSCREENS | DSM IP Assets B.V. (NL) | 2005-03-23 | — | — | EP | disclosed |
| WO-2004000256-A1 | BENZOXAZOLE AND BENZODIAZOLE UV-A SUNSCREENS | DSM IP ASSETS B.V. (NL) | 2003-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050260144-A1 | Benzoxazole and benzodiazole uv-a sunscreens | SUN2, CYP27B1, ERCC4 | ESR1 1458/4885ESR2 2126/4885NPC1 919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.